A New Molecular Link between the Fibrillar and Granulovacuolar Lesions of Alzheimer's Disease

1999/10/01 by Nupur Ghoshal, John F. Smiley, Anthony J. DeMaggio +4 · 27 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Alzheimer's disease #Alzheimer's disease research and treatments #Amino Acid Enzymes and Metabolism #Biochemistry #Biology #Casein kinase 1 #Cell biology #Disease #Gene #Gene isoform #Hippocampus #Hyperphosphorylation #Kinase #Medicine #Neocortex #Neuroscience #Pathology #Prion Diseases and Protein Misfolding #Protein kinase A #Senile plaques #Tau protein

paper · pdf · doi:10.1016/s0002-9440(10)65219-4

openalex publication_date 1999/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Cited by

• TDP‐43 Phosphorylation: Pathological Modification or Protective Factor Antagonizing TDP‐43 Aggregation in Neurodegenerative Diseases?
• Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases
• Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. [europepmc]
• Physiological role for casein kinase 1 in glutamatergic synaptic transmission. [europepmc]
• Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis. [europepmc]
• Mechanisms of tau-induced neurodegeneration. [europepmc]
• Tau in Alzheimer disease and related tauopathies. [europepmc]
• Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. [europepmc]
• Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates. [europepmc]
• Hyperphosphorylation-induced tau oligomers. [europepmc]
• Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β. [europepmc]
• MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies. [europepmc]
• Hrr25/CK1δ-directed release of Ltv1 from pre-40S ribosomes is necessary for ribosome assembly and cell growth. [europepmc]
• Identification of modulators of autophagic flux in an image-based high content siRNA screen. [europepmc]
• Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK. [europepmc]
• Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer's disease. [europepmc]
• Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology. [europepmc]
• Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies. [europepmc]
• Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. [europepmc]
• Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. [europepmc]
• Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity. [europepmc]
• The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease. [europepmc]
• Lithium and Therapeutic Targeting of GSK-3. [europepmc]
• The Molecular Clock and Neurodegenerative Disease: A Stressful Time. [europepmc]
• Casein Kinase 1 and Human Disease: Insights From the Circadian Phosphoswitch. [europepmc]
• Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study. [europepmc]
• Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration. [europepmc]